Nevertheless, in gastrointestinal carcinomas, such as GC and colorectal cancer (CRC), patients with MerTK overexpression show a poor prognosis,21, 22 while the underlying mechanism is still poorly studied.22 This evidence concerns the gene MERTK and gastric cancer.